RESTEN-MP

DRUG2 trials

Sponsors

Sarepta Therapeutics, Inc.

Conditions

Coronary Artery DiseaseCoronary RestenosisCoronary Stent Restenosis

Phase 1

A Phase 1b Study Evaluating RESTEN-MP in Subjects With Focal de Novo Stenosis

TerminatedNCT00244647

Sarepta Therapeutics, Inc.Coronary Artery Disease, Coronary Stent Restenosis

Start: 2003-08-31Target: 40Updated: 2008-04-10

Phase 2

Safety and Efficacy of RESTEN-MP When Used in Conjunction With a Bare Metal Stent in Coronary Arteries

CompletedNCT00248066

Sarepta Therapeutics, Inc.Coronary Artery Disease, Coronary Restenosis

Start: 2005-09-30Target: 50Updated: 2007-02-08